Ripple Point Capital

Ripple Point CapitalRipple Point CapitalRipple Point Capital

Ripple Point Capital

Ripple Point CapitalRipple Point CapitalRipple Point Capital
  • Home
  • About Us
  • Portfolio
  • Team
  • Contact
  • More
    • Home
    • About Us
    • Portfolio
    • Team
    • Contact
  • Home
  • About Us
  • Portfolio
  • Team
  • Contact

Investments within Ripple Point Capital

Zetagen Therapeutics

Zetagen Therapeutics

Zetagen Therapeutics

Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and primary cancers to bone and other organs which may provide increased survival rates. Their multi-patented, ZetaMet™ (Zeta-BC-003) therapy is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone with the potential to increase survival rates.

eLux medical

Zetagen Therapeutics

Zetagen Therapeutics

eLux Medical is working towards establishing a novel, technology advances, best-in-class procedure to provide patients and physicians with a safer, less invasive and more effective fat removal procedure. It is intended that patients will demonstrate higher satisfaction scores due to faster recovery times with fewer complications.

Tiny Cargo Company

Tiny Cargo Company

Tiny Cargo Company

The Tiny Cargo Company manufacturer and supplier of mammalian milk exosomes for use in nutraceutical and therapeutic applications. their team of leading scientist and biotechnicians are based in Virginia, USA.

Compass Biomedical

Tiny Cargo Company

Tiny Cargo Company

Compass Biomedical is a research-focused company developing innovative solutions for cell culture, tissue repair, wound care and ophthalmic therapies. In addition, Compass offers contract research and manufacturing services.

Copyright © 2026 Ripple Point Capital - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept